Skip to main content
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
editorial
. 1983 Feb 19;286(6365):583–585. doi: 10.1136/bmj.286.6365.583

Ampicillin and alternatives.

A Dyas, R Wise
PMCID: PMC1546819  PMID: 6402157

Full text

PDF
583

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Acred P., Hunter P. A., Mizen L., Rolinson G. N. -amino-p-hydroxybenzylpenicillin (BRL 2333), a new broad-spectrum semisynthetic penicillin: in vivo evaluation. Antimicrob Agents Chemother (Bethesda) 1970;10:416–422. [PubMed] [Google Scholar]
  2. Basch H., Erickson R., Gadebusch H. Epicillin: in vitro laboratory studies. Infect Immun. 1971 Jul;4(1):44–49. doi: 10.1128/iai.4.1.44-49.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bass J. W., Crowley D. M., Steele R. W., Young F. S., Harden L. B. Adverse effects of orally administered ampicillin. J Pediatr. 1973 Jul;83(1):106–108. doi: 10.1016/s0022-3476(73)80328-2. [DOI] [PubMed] [Google Scholar]
  4. Bodin N. O., Ekström B., Forsgren U., Jalar L. P., Magni L., Ramsay C. H., Sjöberg B. Bacampicillin: a new orally well-absorbed derivative of ampicillin. Antimicrob Agents Chemother. 1975 Nov;8(5):518–525. doi: 10.1128/aac.8.5.518. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Brogeden R. N., Speight T. M., Avery G. S. Amoxycillin: A review of its antibacterial and pharmacokinietic properties and therapeutic use. Drugs. 1975;9(2):88–140. doi: 10.2165/00003495-197509020-00002. [DOI] [PubMed] [Google Scholar]
  6. Davies B., Maesen F. Serum and sputum antibiotic levels after ampicillin, amoxycillin and bacampicillin chronic bronchitis patients. Infection. 1979;7 (Suppl 5):S465–S468. doi: 10.1007/BF01659773. [DOI] [PubMed] [Google Scholar]
  7. Fang L. S., Tolkoff-Rubin N. E., Rubin R. H. Efficacy of single-dose and conventional amoxicillin therapy in urinary-tract infection localized by the antibody-coated bacteria technic. N Engl J Med. 1978 Feb 23;298(8):413–416. doi: 10.1056/NEJM197802232980802. [DOI] [PubMed] [Google Scholar]
  8. Gold J. A., Hegarty C. P., Deitch M. W., Walker B. R. Double-blind clinical trials of oral cyclacillin and ampicillin. Antimicrob Agents Chemother. 1979 Jan;15(1):55–58. doi: 10.1128/aac.15.1.55. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gordon C., Regamey C., Kirby W. M. Comparative clinical pharmacology of amoxicillin and ampicillin administered orally. Antimicrob Agents Chemother. 1972 Jun;1(6):504–507. doi: 10.1128/aac.1.6.504. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Harbord R. B., Grüneberg R. N. Treatment of urinary tract infection with a single dose of amoxycillin, co-trimoxazole, or trimethoprim.. Br Med J (Clin Res Ed) 1981 Nov 14;283(6302):1301–1302. doi: 10.1136/bmj.283.6302.1301. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hertz C. G. Serum and urinary concentrations of cyclacillin in humans. Antimicrob Agents Chemother. 1973 Sep;4(3):361–365. doi: 10.1128/aac.4.3.361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Hunter P. A., Rolinson G. N., Witting D. A. Comparative activity of amoxycillin and ampicillin in an experimental bacterial infection in mice. Antimicrob Agents Chemother. 1973 Sep;4(3):285–293. doi: 10.1128/aac.4.3.285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Leigh D. A., Marriner J., Fabb S. Treatment of domiciliary urinary tract infections with a single dose of amoxycillin. J Antimicrob Chemother. 1980 May;6(3):403–405. doi: 10.1093/jac/6.3.403. [DOI] [PubMed] [Google Scholar]
  14. Leigh D. A., Reeves D. S., Simmons K., Thomas A. L., Wilkinson P. J. Talampicillin: a new derivative of ampicillin. Br Med J. 1976 Jun 5;1(6022):1378–1380. doi: 10.1136/bmj.1.6022.1378. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Moss F., McNicol M. W., McSwiggan D. A., Miller D. L. Survey of antibiotic prescribing in a district general hospital. I. Pattern of use. Lancet. 1981 Aug 15;2(8242):349–352. doi: 10.1016/s0140-6736(81)90657-7. [DOI] [PubMed] [Google Scholar]
  16. Roseman S. B., Weber L. S., Owen G., Warren G. H. Antimicrobial activity and pharmacological distribution of Wy-4508, an aminoalicyclic penicillin. Antimicrob Agents Chemother (Bethesda) 1967;7:590–596. [PubMed] [Google Scholar]
  17. Shanson D. C., Ashford R. F., Singh J. High-dose oral amoxycillin for preventing endocarditis. Br Med J. 1980 Feb 16;280(6212):446–446. doi: 10.1136/bmj.280.6212.446. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Verbist L. Triple crossover study on absorption and excretion of ampicillin, pivampicillin, and amoxycillin. Antimicrob Agents Chemother. 1974 Nov;6(5):588–593. doi: 10.1128/aac.6.5.588. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES